Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yogliptin multiple-dose phase 2 study in type 2 diabetes
ChiCTR2100050592Phase 2Completed
- Sponsor
- China-Japan Friendship Hospital
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of yogliptin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Safety and tolerability. Started May 2019; status: completed.
02
Drugs
yogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2100050592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050592.